Or give us a call at:
12
Years
12 YEARS OF EXCELLENCE
$78+M
AD SPEND MANAGED
390k+
Leads Delivered
Real Customers, Real Satisfaction
"Craig is one of the best-paid search strategists with whom I've ever had the pleasure of working. His clients should feel assured that they're in great hands when they work with Craig - without a doubt."
Abhilash Patel
Digital Marketing Executive
"I've seen BetterPPC consistently produce immense cost savings in account after account, generating new revenue and profits for clients. Their persistent focus on performance and ROI puts them in a league of their own."
Troy Ireland
CEO Digital Current
To get a Custom Quote Today
Or give us a call at:
Prices are constantly changing and tend to rise over time. It’s easy to get our latest price sheet delivered to your inbox by filling in your name and email address below.
Then you can schedule a call with us to get a more custom quote that will lock in our best rates!
* I agree to receive emails, text messages, and phone calls regarding my inquiry, which may be considered advertising material. Emails, text messages, and phone calls may be automatically generated using the information from the above form to better coordinate communication. I understand my consent to this is not necessary to obtain services from Legal Calls. MSG and Data Rates may apply.
The drug marketed under the brand name Elmiron and known under its generic term “pentosan polysulfate sodium” was developed and manufactured by Janssen Pharmaceuticals (a division of the more well-known parent company Johnson & Johnson).
Elmiron was approved by the FDA in the United States in 1996 for use in treating interstitial cystitis (IC), also known as painful bladder syndrome.
In August of 2018, doctors began to notice a clear link between eye-related injuries and Elmiron. In the last few years since then, a growing body of evidence has been building up. For example, numerous studies show a clear link between the drug and severe eye injuries in a substantial percentage of people taking Elmiron over a long time.
From 1996 to June 2021, the warning of side effects disclosed by Janssen Pharmaceuticals did not include the risk of eye injuries, such as a disease known as macular retinopathy. Macular retinopathy (or maculopathy) can lead to severe vision problems, including permanent blindness.
The central claim in the hundreds of Elmiron cases litigated around the United States is that the manufacture of the drug was negligent because of failure to warn of eye-related injuries. Therefore, consumers could not make informed decisions about their health and the associated risks of taking Elmiron.
Because of early-stage development in the current cases (with no verdicts or settlements reached as of October 2021), there are some risks associated with Elmiron injury cases. At the same time, Elmiron is another “ground floor opportunity” mass tort with the potential for a HUGE return on investment and conversions.
The timing also seems fitting. After several years of attorney advertising to create awareness for those taking Elmiron, momentum is growing. As a result, more and more victims are starting to seek out PI attorneys for injuries related to Elmiron.
The opportunity for Elmiron cases has never been better. Let us help you grow your firm with these new emerging Elmiron mass tort cases! With this ground floor opportunity, it could be one of the best investments for your legal practice.
To get a Custom Quote Today
Or give us a call at: